EUVIMEDEUVIMED entdecken
Crossref

I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?

Farhad Mehrtash, Jody Dushay, JoAnn E Manson

JAMA Internal Medicine · 01.09.2025 · 185 (9) · 1180

DOI: 10.1001/jamainternmed.2025.1133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.09.2025. Verfasst von Farhad Mehrtash und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Die Arbeit wurde bisher 22-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.

Autor:innen und Institutionen

  • Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Division of Endocrinology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Zitieren

APA

Mehrtash, F., Dushay, J., & Manson, J. E. (2025). I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?. JAMA Internal Medicine, 185(9), 1180. https://doi.org/10.1001/jamainternmed.2025.1133

Vancouver

Mehrtash F, Dushay J, Manson JE. I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?. JAMA Internal Medicine. 2025;185(9):1180. doi:10.1001/jamainternmed.2025.1133

BibTeX
@article{Mehrtash2025,
  author = {Mehrtash, Farhad and Dushay, Jody and Manson, JoAnn E},
  title = {I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?},
  journal = {JAMA Internal Medicine},
  year = {2025},
  volume = {185},
  number = {9},
  pages = {1180},
  doi = {10.1001/jamainternmed.2025.1133}
}
Kostenlos starten →